CITRATE DE CAFEINE COOPER 25 mg/ml, solution for injection and oral 10 ampoules of 2 ml
Active ingredients: Citric acid, Caffeine, Caffeine citrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection and oral10 ampoules of 2 mlintraveineuse;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CITRATE DE CAFEINE COOPER 25 mg/mL, solution injectable et buvable
- Pharmaceutical form
- solution injectable et buvable
- Route of administration
- intraveineuse;orale
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Feb 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65973294CIP73453593CIP133400934535932Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE CITRIQUE ANHYDREsolution | 12,5 mg · une solution de 1,0 ml | FT |
| CAFÉINEsolution | 12,5 mg · une solution de 1,0 ml | FT |
| CAFÉINE (CITRATE DE)solution | 25,0 mg · une solution de 1,0 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.